Phase II OVARIO Study of niraparib + bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab
Melissa M. Hardesty, Thomas C. Krivak, Gail S. Wright, Erika Hamilton, Evelyn Fleming, J Belotte, Erika Krasnickas Keeton, Jian Chen, Aine Clements, Heidi J. Gray, Gottfried E. Konecny, Richard G. Moore, Debra L. Richardson
Topics & Concepts
BevacizumabMedicineChemotherapyOvarian cancerOlaparibInternal medicineCarboplatinOncologyDebulkingClinical endpointProgressive diseaseSerous fluidSurgeryCancerCisplatinClinical trialPolymeraseBiochemistryPoly ADP ribose polymeraseGeneChemistryPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentCytomegalovirus and herpesvirus research